Primary Care/Hospitalist
RSSArticles
-
VTE Occurs Frequently in Patients with Sepsis
The purpose of this multicenter study was to prospectively determine the incidence of VTE among ICU patients with sepsis and septic shock, and to identify independent risk factors for VTE in these patients.
-
Inferior Vena Cava Filters and Recurrent Pulmonary Embolism
Placement of retrievable inferior vena cava filters in individuals with concurrent DVT does not reduce the risk of recurrent pulmonary embolism.
-
Clinical Briefs
Distinguishing the major differences within the class of beta-blockers; delay in the diagnosis of hepatocellular carcinoma; and a closer look at an under-recognized form of orthostatic hypotension.
-
Isavuconazonium Sulfate Capsules and Injection (Cresemba ®)
Isavuconazole provides an alternative for the treatment of invasive aspergillosis and mucormycosis.
-
Can Dietary Intervention Delay the Onset of Alzheimer’s Disease?
Targeted nutritional interventions are an evidence-based and safe means of reducing the risk of Alzheimer's disease and cognitive decline.
-
Lowering LDL with Ezetimibe
The combination of simvastatin and ezetimibe resulted in significantly lower LDL levels and a lower risk of cardiovascular events than occurred in patients who are treated with statin monotherapy.
-
Zinc Supplementation: A Risk for Copper Deficiency
Zinc deficiency is frequently misdiagnosed based on a low level without considering albumin concentration and/or an inflammatory state.
-
ECG Review: Sinus Tachycardia with Tall, Peaked T Waves
If told that this patient was having new-onset chest pain we would wonder why his heart rate is so fast, and we would clearly be concerned that the prominent T wave peaking might be ischemic or a DeWinter T wave equivalent.
-
Clinical Briefs
In this issue: flat basal insulin, another possible interventional fix for atrial fibrillation, and a glimmer of hope for beta-blockers in heart failure from diastolic dysfunction.
-
Tedizolid Phosphate Injection and Tablets (Sivextro®)
A new oxazolidinone-class antibacterial has been approved for the treatment of acute bacterial skin and skin structure infections.